Carmat SA (id:10832 ALCAR)
1.17 EUR
Opening hours: 09:00 - 17:30 (Central European Standard Time: 11/28/2024 1:45:08 AM)
Exchange closed, opens in 7 hours 14 minutes
1.39 EUR (1.39%)
-2.50 EUR (-2.50%)
-22.00 EUR (-22.00%)
-64.00 EUR (-64.00%)
-68.55 EUR (-68.55%)
-94.03 EUR (-94.03%)
-98.35 EUR (-98.35%)
-98.75 EUR (-98.75%)
About Carmat SA
Market Capitalization 49.81M
Carmat SA designs and develops total artificial heart for people suffering from end-stage biventricular heart failure in France and internationally. Its product includes Aeson, an active implantable medical device intended to replace the ventricles of the native heart in patients suffering from advanced heart failure. The company was incorporated in 2008 and is headquartered in Vélizy-Villacoublay, France.
| Headquarters (address) |
36, avenue de l'Europe Vélizy-Villacoublay 78140 France |
| Phone | 33 1 39 45 64 50 |
| Website | https://www.carmatsa.com |
| Employees | 162 |
| Sector | Healthcare |
| Industry | Medical Devices |
| Ticker | ALCAR |
| Exchange | European Stock Exchange |
| Currency | EUR |
| 52 week range | 1.01 - 9.99 |
| Market Capitalization | 49.81M |
| P/E trailing | -0.538 |
| P/E forward | -0.472 |
| Price/Sale | 7.19 |
| Beta | 1.39 |
| EPS | -1.68 |
| EPS France (ID:70, base:331) | 3.06 |